Literature DB >> 23720720

Cell-cell contact-mediated hepatitis C virus (HCV) transfer, productive infection, and replication and their requirement for HCV receptors.

Ziqing Liu1, Johnny J He.   

Abstract

Hepatitis C virus (HCV) infection is believed to begin with interactions between cell-free HCV and cell receptors that include CD81, scavenger receptor B1 (SR-B1), claudin-1 (CLDN1), and occludin (OCLN). In this study, we have demonstrated that HCV spreading from infected hepatocytes to uninfected hepatocytes leads to the transfer of HCV and the formation of infection foci and is cell density dependent. This cell-cell contact-mediated (CCCM) HCV transfer occurs readily and requires all these known HCV receptors and an intact actin cytoskeleton. With a fluorescently labeled replication-competent HCV system, the CCCM transfer process was further dissected by live-cell imaging into four steps: donor cell-target cell contact, formation of viral puncta-target cell conjugation, transfer of viral puncta, and posttransfer. Importantly, the CCCM HCV transfer leads to productive infection of target cells. Taken together, these results show that CCCM HCV transfer constitutes an important and effective route for HCV infection and dissemination. These findings will aid in the development of new and novel strategies for preventing and treating HCV infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23720720      PMCID: PMC3719812          DOI: 10.1128/JVI.01062-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  80 in total

1.  Budding of Marburgvirus is associated with filopodia.

Authors:  Larissa Kolesnikova; Aparna B Bohil; Richard E Cheney; Stephan Becker
Journal:  Cell Microbiol       Date:  2006-11-28       Impact factor: 3.715

2.  Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis.

Authors:  Audrey Codran; Cathy Royer; Daniel Jaeck; Michèle Bastien-Valle; Thomas F Baumert; Marie Paule Kieny; Carlos Augusto Pereira; Jean-Pierre Martin
Journal:  J Gen Virol       Date:  2006-09       Impact factor: 3.891

3.  In vitro cell fusion between CD4(+) and HIV-1 Env(+) T cells generates a diversity of syncytia varying in total number, size and cellular content.

Authors:  N López-Balderas; L Huerta; C Villarreal; E Rivera-Toledo; G Sandoval; C Larralde; E Lamoyi
Journal:  Virus Res       Date:  2006-10-02       Impact factor: 3.303

4.  Different domains of CD81 mediate distinct stages of hepatitis C virus pseudoparticle entry.

Authors:  Claire Bertaux; Tatjana Dragic
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

5.  Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses.

Authors:  George Koutsoudakis; Artur Kaul; Eike Steinmann; Stephanie Kallis; Volker Lohmann; Thomas Pietschmann; Ralf Bartenschlager
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

Review 6.  Neutralizing antibodies in hepatitis C virus infection.

Authors:  Mirjam-B Zeisel; Samira Fafi-Kremer; Isabel Fofana; Heidi Barth; Francoise Stoll-Keller; Michel Doffoel; Thomas-F Baumert
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

7.  High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein.

Authors:  Maria Teresa Catanese; Rita Graziani; Thomas von Hahn; Martine Moreau; Thierry Huby; Giacomo Paonessa; Claudia Santini; Alessandra Luzzago; Charles M Rice; Riccardo Cortese; Alessandra Vitelli; Alfredo Nicosia
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

8.  Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry.

Authors:  Matthew J Evans; Thomas von Hahn; Donna M Tscherne; Andrew J Syder; Maryline Panis; Benno Wölk; Theodora Hatziioannou; Jane A McKeating; Paul D Bieniasz; Charles M Rice
Journal:  Nature       Date:  2007-02-25       Impact factor: 49.962

9.  Diverse CD81 proteins support hepatitis C virus infection.

Authors:  Mike Flint; Thomas von Hahn; Jie Zhang; Michelle Farquhar; Christopher T Jones; Peter Balfe; Charles M Rice; Jane A McKeating
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

10.  Immunogenic and functional organization of hepatitis C virus (HCV) glycoprotein E2 on infectious HCV virions.

Authors:  Zhen-Yong Keck; Jinming Xia; Zhaohui Cai; Ta-Kai Li; Ania M Owsianka; Arvind H Patel; Guangxiang Luo; Steven K H Foung
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

View more
  12 in total

1.  Attachment and Postattachment Receptors Important for Hepatitis C Virus Infection and Cell-to-Cell Transmission.

Authors:  Huahao Fan; Luhua Qiao; Kyung-Don Kang; Junfen Fan; Wensheng Wei; Guangxiang Luo
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

2.  The Serum Very-Low-Density Lipoprotein Serves as a Restriction Factor against Hepatitis C Virus Infection.

Authors:  Jian Tao; Kyung-Don Kang; Stacy D Hall; Audra H Laube; Jia Liu; Matthew B Renfrow; Jan Novak; Guangxiang Luo
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

3.  Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency.

Authors:  Pelagia Foka; Alexios Dimitriadis; Eirini Karamichali; Eleni Kyratzopoulou; Dionyssios Giannimaras; John Koskinas; Agoritsa Varaklioti; Avgi Mamalaki; Urania Georgopoulou
Journal:  Virulence       Date:  2016-04-08       Impact factor: 5.882

4.  Editorial on "Broadly neutralizing antibodies abrogate established hepatitis C virus infection" published in Science Translational Medicine on 17th September 2014.

Authors:  Heidi E Drummer
Journal:  Ann Transl Med       Date:  2015-05

5.  Monoclonal Antibodies against Occludin Completely Prevented Hepatitis C Virus Infection in a Mouse Model.

Authors:  Yoshimi Shimizu; Yoshitaka Shirasago; Masuo Kondoh; Tetsuro Suzuki; Takaji Wakita; Kentaro Hanada; Kiyohito Yagi; Masayoshi Fukasawa
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

6.  Hepatitis C virus (HCV) interaction with astrocytes: nonproductive infection and induction of IL-18.

Authors:  Ziqing Liu; Fang Zhao; Johnny J He
Journal:  J Neurovirol       Date:  2014-03-27       Impact factor: 2.643

7.  Apolipoprotein E, but Not Apolipoprotein B, Is Essential for Efficient Cell-to-Cell Transmission of Hepatitis C Virus.

Authors:  Virgínia Gondar; Francisca Molina-Jiménez; Takayuki Hishiki; Luisa García-Buey; George Koutsoudakis; Kunitada Shimotohno; Ignacio Benedicto; Pedro L Majano
Journal:  J Virol       Date:  2015-07-22       Impact factor: 5.103

8.  A combined proteomics/genomics approach links hepatitis C virus infection with nonsense-mediated mRNA decay.

Authors:  Holly R Ramage; G Renuka Kumar; Erik Verschueren; Jeffrey R Johnson; John Von Dollen; Tasha Johnson; Billy Newton; Priya Shah; Julie Horner; Nevan J Krogan; Melanie Ott
Journal:  Mol Cell       Date:  2015-01-22       Impact factor: 17.970

9.  Nef inhibits HIV transcription and gene expression in astrocytes and HIV transmission from astrocytes to CD4+ T cells.

Authors:  Suresh R Kandel; Xiaoyu Luo; Johnny J He
Journal:  J Neurovirol       Date:  2022-08-24       Impact factor: 3.739

10.  Live Cell Imaging of Hepatitis C Virus Trafficking in Hepatocytes.

Authors:  Yasmine Baktash; Glenn Randall
Journal:  Methods Mol Biol       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.